MedPath

Brazilian Randomized Study - Impact of MRI for Breast Cancer

Not Applicable
Conditions
Breast Cancer
Interventions
Device: MRI
Registration Number
NCT02798796
Lead Sponsor
University of Sao Paulo General Hospital
Brief Summary

The aim of this study is to evaluate the ability of MRI to select patients for conservative treatment of breast cancer. Participants: female, over 18 years with breast cancer, stages I, II and III candidates for conservative surgery will be randomly randomized to do MRI or not according mammary density.

Detailed Description

The aim of this study is to evaluate the ability of MRI to select patients for conservative treatment of breast cancer.An accurate assessment of the tumor is essential to select the best therapeutic strategy in the treatment of breast cancer.Currently, mammography, ultrasound and clinical examination are the standard techniques to assess the extent and location of the tumor.However, these imaging methods fail to assess the real size in approximately one third of patients eligible to conservative treatment.MRI has high sensitivity (95-100%) in the detection of invasive cancers as well as being able to detect hidden tumors, multifocality, multicentricity and cancer in the contralateral breast more often and greater accuracy than mammography or ultrasound.

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
372
Inclusion Criteria
  • Female,
  • Over 18 years with breast cancer
  • Clinical stages I, II and III candidates for conservative surgery
Exclusion Criteria
  • Contra-indication for breast MRI (ex. Metal implant)
  • Claustrophobia
  • Impossibility to stay in the prone position for more than an hour
  • History of allergic reaction to the paramagnetic contrast
  • History of chronic kidney disease on dialysis
  • Personal history of breast cancer treated surgically in the last 12 months.
  • Pregnancy or breastfeeding past 6 months

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
MRI GroupMRIMRI Group - all patients will be submitted to clinical examination, mammography and / or ultrasound, and breast MRI
Primary Outcome Measures
NameTimeMethod
False positive rate, false negative rate, positive predictive value and negative predictive value MRI in the Breast Cancer conservative surgery3 years
Secondary Outcome Measures
NameTimeMethod
Describe the percentage of positive margins on pathological examination3 years
Describe the percentage surgical change from conservative surgery to mastectomy3 years
Calculate the False positive rate, false negative rate , positive predictive value and negative predictive value according mammographic density, molecular subtype and histopathology of the tumor3 years
Calculate the period after successful treatment in which there is no appearance of the symptoms or effects of the disease after 3 and 5 years bettwen groups5 years
Calculate how much is the cost to do the exam considering the false positive and false negative rates3 years
Describe the percentage of additional surgery rates3 years

Trial Locations

Locations (1)

Universidade de São Paulo

🇧🇷

São Paulo, Brazil

© Copyright 2025. All Rights Reserved by MedPath